Literature DB >> 14550906

Alpha-synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone.

M Orth1, S J Tabrizi, A H V Schapira, J M Cooper.   

Abstract

Mitochondrial dysfunction has been implicated in the aetiology of sporadic Parkinson's disease but its role in the disease mechanism is not clear. We have investigated the short term effect of G209A mutant or wild-type alpha-synuclein expression upon mitochondrial function using stable inducible cell models. Mitochondrial respiratory chain activities and membrane potential were normal suggesting that increased wild-type or mutant alpha-synuclein expression did not directly affect these parameters. However, both wild-type and mutant G209A alpha-synuclein expression enhanced the fall in mitochondrial membrane potential induced by the complex I inhibitor rotenone. This suggests an indirect interaction between alpha-synuclein expression and mitochondrial function which could render the mitochondria more vulnerable to inhibition by potential endogenous or exogenous factors found in dopaminergic neurones.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550906     DOI: 10.1016/s0304-3940(03)00941-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

Review 1.  The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

Review 2.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

3.  Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.

Authors:  Yufeng Yang; Stephan Gehrke; Yuzuru Imai; Zhinong Huang; Yingshi Ouyang; Ji-Wu Wang; Lichuan Yang; M Flint Beal; Hannes Vogel; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

Review 4.  Mitochondrial dynamics and Parkinson's disease: focus on parkin.

Authors:  Kah-Leong Lim; Xiao-Hui Ng; Lim Gui-Yin Grace; Tso-Pang Yao
Journal:  Antioxid Redox Signal       Date:  2011-07-22       Impact factor: 8.401

Review 5.  Environmental toxins and alpha-synuclein in Parkinson's disease.

Authors:  Yanying Liu; Hui Yang
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 6.  A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

7.  Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1.

Authors:  Frits Kamp; Nicole Exner; Anne Kathrin Lutz; Nora Wender; Jan Hegermann; Bettina Brunner; Brigitte Nuscher; Tim Bartels; Armin Giese; Klaus Beyer; Stefan Eimer; Konstanze F Winklhofer; Christian Haass
Journal:  EMBO J       Date:  2010-09-14       Impact factor: 11.598

Review 8.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

Review 9.  Regulation of autophagy by mitochondrial phospholipids in health and diseases.

Authors:  Paul Hsu; Yuguang Shi
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-08-05       Impact factor: 4.698

Review 10.  Mitochondrial morphogenesis, distribution, and Parkinson disease: insights from PINK1.

Authors:  Yufeng Yang; Bingwei Lu
Journal:  J Neuropathol Exp Neurol       Date:  2009-09       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.